Banyan Biomarkers is a startup based in the United States, 1 tracked investor.
Based in the United States, Banyan Biomarkers is a startup. Brouky records 1 investor associated with the company.
Banyan Biomarkers developed the first FDA-approved blood test that detects mild traumatic brain injuries (TBIs).
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.